{"id":"NCT01136954","sponsor":"Eisai Limited","briefTitle":"A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)","officialTitle":"An Open-label Extension Study Following a Double-blind, Randomized, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Pediatric Partial Onset Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07","primaryCompletion":"2012-01","completion":"2012-03","firstPosted":"2010-06-04","resultsPosted":"2013-02-06","lastUpdate":"2016-01-25"},"enrollment":144,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Partial Seizures"],"interventions":[{"type":"DRUG","name":"Zonisamide","otherNames":["Zonegran"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the long-term safety and efficacy of zonisamide used as an adjunctive treatment in pediatric subjects treated with 1 or 2 other anti-epileptic drugs (AEDs).","primaryOutcome":{"measure":"Treatment Emergent Non-Serious Adverse Events With Greater Than 5% Frequency","timeFrame":"Week 1 through Week 59","effectByArm":[{"arm":"Zonisamide (Placebo During Core Study)","deltaMin":6,"sd":null},{"arm":"Zonisamide (Zonisamide During Core Study)","deltaMin":9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":72},"commonTop":["Nasopharyngitis","Weight decreased","Headache","Decreased Appetite","Bronchitis"]}}